SteelcoBelimed Sets the Course for Growth and Profitability

Zug, September 30, 2024 – The SteelcoBelimed joint venture, in which Metall Zug holds a 33% stake, has unveiled its plans to achieve growth and profitability targets. The strategy focuses on existing locations, product portfolio streamlining, and organizational consolidation. The integration phase, lasting around three years, aims for an EBIT margin of 10% in the medium term.

SteelcoBelimed, headquartered in Zug, retained its key production sites in Sulgen, Grosuplje, Riese, and Cusano for focused purposes. The company will follow a dual-brand strategy and streamline its products. The organization will be divided into two business units: Infection Control and Life Science, each led by experienced former CEOs of Steelco and Belimed, respectively.

These measures aim to make SteelcoBelimed the third largest global market player in cleaning, disinfection, and sterilization. Metall Zug will continue to invest in the venture to participate in future value creation, reporting bi-annually on its business performance.